Records containing: Lung Cancer Stage III

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-21
A Multicenter Phase II Trial of Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
CLINICAL_TRIALS study record update · 2026-04-21
Neoadjuvant Umbrella Trial Directed by Next Generation Sequencing for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations (Without EGFR Sensitizing Mutations)
CLINICAL_TRIALS study record update · 2025-10-20
Phase 2 Trial of Neoadjuvant Nivolumab + Platinum-based Chemotherapy + Certolizumab in Patients With Resectable Stages II-III Lung Cancers
CLINICAL_TRIALS study record update · 2025-10-02
Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy: A Prospective Longitudinal Cohort
CLINICAL_TRIALS study record update · 2025-05-15
A Study on the Safety and Efficacy of Using Cingular Bovine Pericardium Anastomosis Reinforcement Membrane for Tissue Reinforcement and Hemostasis at Anastomotic Sites
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2025-04-30
Phase II Study of Induction Platinum Doublet in Combination With Nivolumab Followed by Surgery or Concurrent Chemoradiation in Unresectable Stage IIIA-C Non-small Cell Lung Cancer (NSCLC)
CLINICAL_TRIALS study record update · 2025-04-16
A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants
CLINICAL_TRIALS study record update · 2025-03-30
GUIding Multi-moDal thErapies Against MRD by LiquidBiopsies in Non Small Cell Lung Cancer- GUIDE.MRD-03-NSCLC
CLINICAL_TRIALS study record update · 2025-03-21
Phase II Concurrent Durvalumab (MEDI4736) and Radiotherapy Followed by Consolidative Durvalumab (MEDI4736) for Stage III Non-Small Cell Lung Cancer (NSCLC)
CLINICAL_TRIALS study record update · 2024-08-29
LCI-LUN-NSC-SBRT-001: Phase II Prospective Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation and Adjuvant Immunotherapy for Locally-Advanced Non-Small Cell Lung Cancer
CLINICAL_TRIALS study record update · 2024-08-09
Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab.
CLINICAL_TRIALS study record update · 2024-02-02
Resilience Measurement, Prediction, and Its Role in Older Adults With Late-Stage Lung Cancer
CLINICAL_TRIALS study record update · 2023-12-06
The Effect of Radiotherapy on the Heart in Loco-regional Advanced NSCLC Patients Treated With Definitive Radiotherapy Measured by Cardiac MR
CLINICAL_TRIALS study record update · 2023-10-17
Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer
CLINICAL_TRIALS study record update · 2023-09-29
Enabling Remote Access to Breathe Easier: A Novel Approach to Improve Symptom Self-Management and Wellness for Survivors of Lung Cancer and Their Family Members
CLINICAL_TRIALS study record update · 2023-09-28
Blue Sky Radiomics: an Observational Study on Computed Tomography as an Image-based Predictive Marker of Response to Chemoradiation Followed by Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer (NSCLC).
CLINICAL_TRIALS study record update · 2023-08-29
Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer：A Randomized Controlled Clinical Trial
CLINICAL_TRIALS study record update · 2022-08-03
Self-System Therapy for Older Adults With Advanced Lung Cancer (SST-LC)